Aptamers
SKU
MRR-4358BACA838E
Region
Global
Publication Date
February 2024
Delivery
Immediate
2023
USD 1.34 billion
2030
USD 2.77 billion
2024
USD 1.48 billion
CAGR
10.91%
Aptamers Market by Product (Nucleotide Based, Peptide Based), Application (Diagnostics, Research & Development, Therapeutics Development), End-User - Global Forecast 2024-2030

[192 Pages Report] The Aptamers Market size was estimated at USD 1.34 billion in 2023 and expected to reach USD 1.48 billion in 2024, at a CAGR 10.91% to reach USD 2.77 billion by 2030.

Aptamers Market
To learn more about this report, request a free sample copy

Aptamers are single-stranded oligonucleotides, including DNA, RNA, or modified nucleic acids, that have the ability to bind specifically and with high affinity to their target molecules. These target molecules can be proteins, peptides, small organic compounds, nucleic acids, or whole cells. The importance of aptamers lies in their numerous applications in biotechnology due to their unique characteristics. They exhibit high specificity and affinity for their targets akin to antibodies and possess advantages such as smaller size, ease of chemical synthesis, and modification for stability, making them suitable candidates for targeted drug delivery systems or diagnostic tools. Moreover, aptamers have minimal immunogenicity compared to antibodies since they comprise natural nucleotides. Aptamers can be engineered for multiplex detection or combined with other biofunctional moieties, such as nanoparticles or fluorophores, to enhance their applicability across various sectors. The aptamers market is experiencing significant growth driven by various factors, such as investments in drug development, government initiatives promoting personalized medicine, and the rising development of aptamer-based biosensors and point-of-care diagnostics. However, challenges such as development complexity and regulatory limitations pose hurdles for the aptamers market. Market players are working on new production technologies to ease the aptamer manufacturing process and improve their quality. Advances in synthetic chemistry and high-throughput screening technologies have enabled the development of modified nucleic acid libraries to generate more stable and functional aptamers.

Aptamers Market - Global Forecast 2024-2030
To learn more about this report, request a free sample copy
Regional Insights

The Americas region exhibits significant advancements in the global aptamer market, with an established biotechnology sector bolstered by a strong academic foundation and substantial investment in R&D activities. In terms of application areas within the Americas region, aptamers are widely used in drug discovery efforts targeting cancer therapy, treatment of inflammatory diseases, diagnosis & management. Significant advancements have been made in employing aptamers for environmental monitoring and food safety applications. Europe represents an evolving landscape for aptamers as countries such as Germany, France, and the UK have advanced biopharmaceutical sectors that use this technology extensively for therapeutic applications or diagnostics tool development. European researchers have made significant strides in using aptamers for agricultural applications, wherein they are employed to detect plant pathogens or monitor food contamination. In Asia, the aptamer landscape is at a nascent stage with potential for rapid growth due to increasing biopharmaceutical investments and government funding initiatives. Emerging markets, including China, India, South Korea, and Japan, are leading regional research activities. Although there is a limited number of dedicated aptamer-based companies in Asia compared to the Americas and Europe, these countries harbor several large-scale pharmaceutical entities that engage in aptamer research as part of their drug discovery pipelines. Asian researchers have demonstrated a growing interest in utilizing aptamers as diagnostic tools or therapeutic agents for chronic disease management, such as cardiovascular ailments or neurodegenerative conditions.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Aptamers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Aptamers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Zentek and McMaster Announce Positive Results for the Aptamer Platform

    Zentek Ltd. and McMaster partnered for the successful testing of their aptamer platform. The aptamer platform exhibits great potential as a prophylactic or therapeutic solution for SARS-CoV-2 in pre-clinical animal models. Remarkably, repeated trials have demonstrated comparable efficacy to a commercial monoclonal antibody specifically designed for combating SARS-CoV-2. This collaborative effort highlights the tremendous potential of aptamers in the fight against SARS-CoV-2. [Published On: 2023-07-23]

  • Aptamer Group and Neuro-Bio Collaborate to Develop Alzheimer’s Disease Diagnostic Test

    Aptamer Group and Neuro-Bio collaborated on a groundbreaking development in the field of Alzheimer's disease diagnosis and the creation of Optimer binders specifically designed to target a particular biomarker. These binders have been engineered to effectively interact with a nasal mucous matrix. By integrating these binders into a lateral flow test, the growth of rapid diagnostics for Alzheimer's disease through nasal sampling will be greatly facilitated. This innovative approach holds immense promise for early detection and diagnosis of Alzheimer's disease, offering new opportunities for timely intervention and treatment. [Published On: 2023-06-16]

  • Launch of Optimer-Fc as a New Reagent Solution for Immunohistochemistry

    Aptamer Group plc developed Optimer-Fc, a new reagent specifically designed for use in automated immunohistochemistry (IHC) workflows. Optimer-Fc is an antibody alternative that utilizes aptamers, serving as a replacement for the primary detecting antibody. These Optimer binders exhibit exceptional selectivity and tuneability, enabling the exploration of both novel and existing disease biomarkers with heightened accuracy and selectivity in detection. [Published On: 2023-03-23]

Key Company Profiles

The report delves into recent significant developments in the Aptamers Market, highlighting leading vendors and their innovative profiles. These include 2bind GmbH, Agilent Technologies, Inc., Aptagen, LLC, Aptamer Group, Aptamer Sciences, Inc., AptaTargets SL, Aptus Biotech S.L., ATDBio Ltd., Base Pair Biotechnologies, Inc., Basking Biosciences, Cage Bio, Inc., Creative Biogene, Drive Therapeutics, LLC, IVERIC bio, Inc., Kaneka Corporation, Maravai LifeSciences, Mediomics, LLC, NeoVentures Biotechnology, Inc., NOVAPTECH, Novartis AG, Qualigen, Inc., Raptamer Discovery Group, SomaLogic, Inc., TAGCyx Biotechnologies Inc., and Vivonics, Inc..

Market Segmentation & Coverage

This research report categorizes the Aptamers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Nucleotide Based
      • DNA
      • RNA
      • XNA
    • Peptide Based
  • Application
    • Diagnostics
    • Research & Development
    • Therapeutics Development
  • End-User
    • Academic & Government Research Institutes
    • Biotechnology & Pharmaceutical Companies
    • Contract Research Organizations

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Aptamers Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Aptamers Market?
  3. What are the technology trends and regulatory frameworks in the Aptamers Market?
  4. What is the market share of the leading vendors in the Aptamers Market?
  5. Which modes and strategic moves are suitable for entering the Aptamers Market?

  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & CoverageAPTAMERS MARKET SEGMENTATION & COVERAGE
    3. Years Considered for the Study
    4. Currency & PricingUNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    5. Language
    6. Limitations
    7. Assumptions
    8. Stakeholders
  2. Research Methodology
    1. APTAMERS MARKET RESEARCH PROCESS
    2. Define: Research Objective
    3. Determine: Research Design
    4. Prepare: Research Instrument
    5. Collect: Data Source
    6. Analyze: Data Interpretation
    7. Formulate: Data Verification
    8. Publish: Research Report
    9. Repeat: Report Update
  3. Executive Summary
    1. APTAMERS MARKET SIZE, 2023 VS 2030
  4. Market Overview
    1. IntroductionAPTAMERS MARKET SIZE, 2018-2030 (USD MILLION)APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
    2. Aptamers Market, by RegionAPTAMERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)APTAMERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)GLOBAL APTAMERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  5. Market Insights
    1. Market DynamicsAPTAMERS MARKET DYNAMICS
      1. Drivers
        1. Investments in drug development and use of aptamers for drug-binding affinity
        2. Government initiatives encouraging personalized medicine and treatment
        3. Rising development of aptamer-based biosensors and point-of-care diagnostics
      2. Restraints
        1. Concerns associated with short half-life of aptamers
      3. Opportunities
        1. Technological advancements in aptamer production and functionalities
        2. Emergence use of aptamers for food safety and authenticity testing
      4. Challenges
        1. Development complexity and regulatory limitations
    2. Market Segmentation Analysis
    3. Market Trend Analysis
    4. Cumulative Impact of High Inflation
    5. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    6. Value Chain & Critical Path Analysis
    7. Regulatory Framework
  6. Aptamers Market, by Product
    1. IntroductionAPTAMERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)APTAMERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
    2. Nucleotide BasedAPTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, BY , 2018-2030 (USD MILLION)
    3. APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
      1. DNAAPTAMERS MARKET SIZE, BY DNA, BY , 2018-2030 (USD MILLION)
      2. RNAAPTAMERS MARKET SIZE, BY RNA, BY , 2018-2030 (USD MILLION)
      3. XNAAPTAMERS MARKET SIZE, BY XNA, BY , 2018-2030 (USD MILLION)
    4. Peptide BasedAPTAMERS MARKET SIZE, BY PEPTIDE BASED, BY , 2018-2030 (USD MILLION)
  7. Aptamers Market, by Application
    1. IntroductionAPTAMERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)APTAMERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    2. DiagnosticsAPTAMERS MARKET SIZE, BY DIAGNOSTICS, BY , 2018-2030 (USD MILLION)
    3. Research & DevelopmentAPTAMERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY , 2018-2030 (USD MILLION)
    4. Therapeutics DevelopmentAPTAMERS MARKET SIZE, BY THERAPEUTICS DEVELOPMENT, BY , 2018-2030 (USD MILLION)
  8. Aptamers Market, by End-User
    1. IntroductionAPTAMERS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)APTAMERS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    2. Academic & Government Research InstitutesAPTAMERS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY , 2018-2030 (USD MILLION)
    3. Biotechnology & Pharmaceutical CompaniesAPTAMERS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY , 2018-2030 (USD MILLION)
    4. Contract Research OrganizationsAPTAMERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY , 2018-2030 (USD MILLION)
  9. Americas Aptamers Market
    1. Introduction
    2. AMERICAS APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)AMERICAS APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)AMERICAS APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)AMERICAS APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    3. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Argentina
    5. ARGENTINA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)ARGENTINA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)ARGENTINA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)ARGENTINA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    6. Brazil
    7. BRAZIL APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)BRAZIL APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)BRAZIL APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)BRAZIL APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    8. Canada
    9. CANADA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)CANADA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)CANADA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)CANADA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    10. Mexico
    11. MEXICO APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)MEXICO APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)MEXICO APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)MEXICO APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    12. United States
    13. UNITED STATES APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)UNITED STATES APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)UNITED STATES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)UNITED STATES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    14. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  10. Asia-Pacific Aptamers Market
    1. Introduction
    2. ASIA-PACIFIC APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)ASIA-PACIFIC APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)ASIA-PACIFIC APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)ASIA-PACIFIC APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    3. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Australia
    5. AUSTRALIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)AUSTRALIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)AUSTRALIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)AUSTRALIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    6. China
    7. CHINA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)CHINA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)CHINA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)CHINA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    8. India
    9. INDIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)INDIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)INDIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)INDIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    10. Indonesia
    11. INDONESIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)INDONESIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)INDONESIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)INDONESIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    12. Japan
    13. JAPAN APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)JAPAN APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)JAPAN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)JAPAN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    14. Malaysia
    15. MALAYSIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)MALAYSIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)MALAYSIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)MALAYSIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    16. Philippines
    17. PHILIPPINES APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)PHILIPPINES APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)PHILIPPINES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)PHILIPPINES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    18. Singapore
    19. SINGAPORE APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SINGAPORE APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)SINGAPORE APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SINGAPORE APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    20. South Korea
    21. SOUTH KOREA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SOUTH KOREA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)SOUTH KOREA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SOUTH KOREA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    22. Taiwan
    23. TAIWAN APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)TAIWAN APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)TAIWAN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)TAIWAN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    24. Thailand
    25. THAILAND APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)THAILAND APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)THAILAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)THAILAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    26. Vietnam
    27. VIETNAM APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)VIETNAM APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)VIETNAM APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)VIETNAM APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  11. Europe, Middle East & Africa Aptamers Market
    1. Introduction
    2. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    3. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Denmark
    5. DENMARK APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)DENMARK APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)DENMARK APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)DENMARK APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    6. Egypt
    7. EGYPT APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)EGYPT APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)EGYPT APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)EGYPT APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    8. Finland
    9. FINLAND APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)FINLAND APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)FINLAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)FINLAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    10. France
    11. FRANCE APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)FRANCE APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)FRANCE APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)FRANCE APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    12. Germany
    13. GERMANY APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)GERMANY APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)GERMANY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)GERMANY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    14. Israel
    15. ISRAEL APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)ISRAEL APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)ISRAEL APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)ISRAEL APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    16. Italy
    17. ITALY APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)ITALY APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)ITALY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)ITALY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    18. Netherlands
    19. NETHERLANDS APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)NETHERLANDS APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)NETHERLANDS APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)NETHERLANDS APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    20. Nigeria
    21. NIGERIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)NIGERIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)NIGERIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)NIGERIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    22. Norway
    23. NORWAY APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)NORWAY APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)NORWAY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)NORWAY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    24. Poland
    25. POLAND APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)POLAND APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)POLAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)POLAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    26. Qatar
    27. QATAR APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)QATAR APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)QATAR APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)QATAR APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    28. Russia
    29. RUSSIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)RUSSIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)RUSSIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)RUSSIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    30. Saudi Arabia
    31. SAUDI ARABIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SAUDI ARABIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)SAUDI ARABIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SAUDI ARABIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    32. South Africa
    33. SOUTH AFRICA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SOUTH AFRICA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)SOUTH AFRICA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SOUTH AFRICA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    34. Spain
    35. SPAIN APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SPAIN APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)SPAIN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SPAIN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    36. Sweden
    37. SWEDEN APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SWEDEN APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)SWEDEN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SWEDEN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    38. Switzerland
    39. SWITZERLAND APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SWITZERLAND APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)SWITZERLAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SWITZERLAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    40. Turkey
    41. TURKEY APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)TURKEY APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)TURKEY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)TURKEY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    42. United Arab Emirates
    43. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    44. United Kingdom
    45. UNITED KINGDOM APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)UNITED KINGDOM APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)UNITED KINGDOM APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)UNITED KINGDOM APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  12. Competitive Landscape
    1. FPNV Positioning MatrixAPTAMERS MARKET, FPNV POSITIONING MATRIX, 2023APTAMERS MARKET, FPNV POSITIONING MATRIX, 2023
    2. Market Share Analysis, By Key PlayerAPTAMERS MARKET SHARE, BY KEY PLAYER, 2023APTAMERS MARKET SHARE, BY KEY PLAYER, 2023
    3. Competitive Scenario Analysis, By Key Player
      1. Zentek and McMaster Announce Positive Results for the Aptamer Platform
      2. Aptamer Group and Neuro-Bio Collaborate to Develop Alzheimer’s Disease Diagnostic Test
      3. Launch of Optimer-Fc as a New Reagent Solution for Immunohistochemistry
      4. Aptamer Opens New Facilities to Meet Growing Demand for Optimer Technology
  13. Competitive Portfolio
    1. Key Company Profiles
      1. 2bind GmbH
      2. Agilent Technologies, Inc.
      3. Aptagen, LLC
      4. Aptamer Group
      5. Aptamer Sciences, Inc.
      6. AptaTargets SL
      7. Aptus Biotech S.L.
      8. ATDBio Ltd.
      9. Base Pair Biotechnologies, Inc.
      10. Basking Biosciences
      11. Cage Bio, Inc.
      12. Creative Biogene
      13. Drive Therapeutics, LLC
      14. IVERIC bio, Inc.
      15. Kaneka Corporation
      16. Maravai LifeSciences
      17. Mediomics, LLC
      18. NeoVentures Biotechnology, Inc.
      19. NOVAPTECH
      20. Novartis AG
      21. Qualigen, Inc.
      22. Raptamer Discovery Group
      23. SomaLogic, Inc.
      24. TAGCyx Biotechnologies Inc.
      25. Vivonics, Inc.
    2. Key Product Portfolio
  1. 2bind GmbH
  2. Agilent Technologies, Inc.
  3. Aptagen, LLC
  4. Aptamer Group
  5. Aptamer Sciences, Inc.
  6. AptaTargets SL
  7. Aptus Biotech S.L.
  8. ATDBio Ltd.
  9. Base Pair Biotechnologies, Inc.
  10. Basking Biosciences
  11. Cage Bio, Inc.
  12. Creative Biogene
  13. Drive Therapeutics, LLC
  14. IVERIC bio, Inc.
  15. Kaneka Corporation
  16. Maravai LifeSciences
  17. Mediomics, LLC
  18. NeoVentures Biotechnology, Inc.
  19. NOVAPTECH
  20. Novartis AG
  21. Qualigen, Inc.
  22. Raptamer Discovery Group
  23. SomaLogic, Inc.
  24. TAGCyx Biotechnologies Inc.
  25. Vivonics, Inc.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Aptamers Market
The Global Aptamers Market size was estimated at USD 1.34 billion in 2023 and expected to reach USD 1.48 billion in 2024.
The Global Aptamers Market to grow USD 2.77 billion by 2030, at a CAGR of 10.91%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.